Zhengye Biotechnology Holding (ZYBT) Total Liabilities (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Total Liabilities for 2 consecutive years, with $19.6 million as the latest value for Q4 2024.
- Quarterly Total Liabilities fell 12.19% to $19.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $19.6 million through Dec 2024, down 12.19% year-over-year, with the annual reading at $19.3 million for FY2024, 15.19% down from the prior year.
- Total Liabilities for Q4 2024 was $19.6 million at Zhengye Biotechnology Holding, down from $22.3 million in the prior quarter.
- The five-year high for Total Liabilities was $22.3 million in Q4 2023, with the low at $19.6 million in Q4 2024.